Publication date: October 2026 Source: European Urology Focus, Volume 12, Issue 5 Author(s): Louise Kostos, James P. Buteau, Arun A. Azad, Michael S. Hofman
Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial. // European Urology Focus. – URL: https://www.sciencedirect.com/science/article/pii/S2405456926000854?dgcid=rss_sd_all
Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial. European Urology Focus. https://www.sciencedirect.com/science/article/pii/S2405456926000854?dgcid=rss_sd_all
“Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial.” European Urology Focus.
@article{article45667,
title = {Radionuclide Combination Strategies in Prostate Cancer: Insights from the AlphaBet Trial},
journal = {European Urology Focus},
url = {https://www.sciencedirect.com/science/article/pii/S2405456926000854?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...